Nandrolone phenylpropionate is a drug that belongs to the group of anabolic steroids . White with a creamy tint crystalline powder. It is soluble in alcohol, practically insoluble in water. It is an active, long-acting anabolic steroid. After a single injection, the effect lasts 7-15 days. It has a weak androgenic effect.
| Nandrolone Phenylpropionate | |
|---|---|
| Nandrolone phenylpropionate | |
| Chemical compound | |
| Gross formula | C 27 H 34 O 3 |
| Cas | |
| PubChem | |
| Drugbank | |
| Classification | |
| Farmakol. Group | anabolic steroid |
| Dosage Forms | |
| ampoule oil solution | |
| Route of administration | |
| Intramuscularly deep | |
| Other names | |
Durabolin, Nerobolil, Turabolil, Phenobolin, Anaboline, Anabosan, Anticatabolin, Durabol, Durabolin, Hormobolin, Hormonabol, Metabol, Nanbolin, Nandrolin, Nandrolonum phenylpropionicum, Nerobolil, Norstenol, Supebolin Turinabol, Unabol, etc. | |
Indications for use
Violations of protein anabolism during cachexia of various origins, asthenia, infectious and other diseases accompanied by protein loss. Severe injuries, operations, burns. Interstitial pituitary insufficiency, chronic adrenal insufficiency, diabetic angiopathies (retinopathies and nephropathies), pituitary dwarfism. Aplastic anemia, peptic ulcer of the stomach and duodenum, chronic kidney disease, accompanied by protein loss and azotemia, chronic lung disease. Osteoporosis, delayed bone marrow formation, large fractures and plastic surgery on bones, myopathy and progressive muscular dystrophy; senile retinal degeneration. Children are prescribed for growth retardation, anorexia, loss of nutrition, etc. For elderly people it is sometimes recommended to improve compensatory and adaptive processes.
Contraindications
Hypertrophy and prostate cancer, acute and chronic prostatitis, acute liver disease, heart failure, coronary heart disease, myocardial infarction , breast cancer, hypercalcemia, pregnancy and lactation.
Dosage and administration
Intramuscularly administered as an oil solution. Assign to adults 1 time in 7-10 days at 0.025-0.05 g (25-50 mg); children - at the rate of 1.0-1.5 mg / kg per month, and ¼ — ⅓ of this dose is administered every 7-10 days. The course of treatment usually lasts 1.5-2 months. If necessary, treatment is repeated after a month's break. For children with growth retardation (with cerebral-pituitary nanism), the drug is administered for a long time (up to 1-2 years). [one]
Side effect
- Headache - 20%
- Rhinitis (discharge from the nose) - 15%
- Back pain - 15%
- Rash - 10%
In addition, during the course sometimes occur: a rise in blood pressure, abdominal pain, irritability, headaches, depression and some other complications.
Notes
- ↑ Mashkovsky M.D. Medicines. - 15th ed., Rev., Rev. and add. - M.: “New Wave”, 2006.— 1206 p.: Ill. ISBN 5-7864-0203-7